Clinical studies recruiting near Mcallen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Gamma Medical Research · R1 Therapeutics · NCT06712654 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Nova Oncology · Eli Lilly and Company · NCT07218380 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Biopharma Informatic-McAllen · Amgen · NCT07037433 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Texas Oncology - Central/South Texas · Pfizer · NCT07421700 EDX110 Randomized Control Trial for Treatment of DFUs
NA · Futuro Clinical Trials · ConvaTec Inc. · NCT07209358 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Valley Retina Institute · Astellas Pharma Global Development, Inc. · NCT06779773 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Texas Oncology -Central South · Pfizer · NCT07144280 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Dr. Ruben Aleman & Associates · Pfizer · NCT07629440 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 162 · Adverum Biotechnologies, Inc. · NCT07482176 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · Texas Oncology - Central South · Pfizer · NCT07227415 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye
Phase 3 · Biopharma Informatic, LLC · Pfizer · NCT05261139 A Study of ZL-1310 in Participants With Selected Solid Tumors
Phase 1/Phase 2 · Zai Lab Site 2011 · Zai Lab (Shanghai) Co., Ltd. · NCT06885281 Project: Every Child for Younger Patients With Cancer
Phase N/A · Vannie Cook Children's Clinic · Children's Oncology Group · NCT02402244 Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Phase 4 · Upsher-Smith Clinical Trial Site #13 · Upsher-Smith Laboratories · NCT04748601 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Biopharma Informatic LLC · Boehringer Ingelheim · NCT06632457 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1063 · Anthos Therapeutics, Inc. · NCT05712200 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Phase 4 · DHR Health Headache Center · Mayo Clinic · NCT06972056 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Valley Retina Institute, P.A. · ONL Therapeutics · NCT06659445 A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC20172
Phase 2 · Valley Retina Institute P.A. · Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. · NCT07395986 A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Texas Oncology - Central/South Texas ( Site 8005) · Merck Sharp & Dohme LLC · NCT07060807 Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · DCT-McAllen Primary Care Research, LLC dba Discovery Clinica · Pfizer · NCT05156398 Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With En
Phase 3 · USOR - Texas Oncology · Genmab · NCT07166094 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Phase 1/Phase 2 · Valley Retina Institute, PA · 4D Molecular Therapeutics · NCT05197270 Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Phase 3 · Futuro Clinical Trials · Medipost, Inc. · NCT07339111 Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Phase 3 · Vannie Cook Children's Clinic · Baylor College of Medicine · NCT02670707 BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 3 · Dr. Ruben Aleman and Associates · Pfizer · NCT07160244 Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 · Texas Oncology - Central South · Pfizer · NCT06952660 A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melan
Phase 3 · Texas Oncology - McAllen · Regeneron Pharmaceuticals · NCT06246916 A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Dis
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06749457

Look up another city

Look up another condition